UB
UTHR icon

UMB Bank’s United Therapeutics UTHR Stock Holding History

UMB Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Sell
1,342
-4
-0.3% -$2.25K 0.01% 413
2026
Q1 		$798K Sell
1,346
-132
-9% -$65.7K 0.01% 393
2025
Q4 		$720K Buy
1,478
+64
+5% +$29.8K 0.01% 412
2025
Q3 		$593K Buy
1,414
+106
+8% +$35.6K 0.01% 405
2025
Q2 		$376K Buy
1,308
+19
+1% +$5.68K 0.01% 463
2025
Q1 		$397K Buy
1,289
+188
+17% +$64.4K 0.01% 438
2024
Q4 		$388K Buy
1,101
+51
+5% +$18.7K 0.01% 439
2024
Q3 		$376K Buy
1,050
+99
+10% +$33.4K 0.01% 448
2024
Q2 		$303K Sell
951
-179
-16% -$47.4K 0.01% 477
2024
Q1 		$260K Sell
1,130
-191
-14% -$43.1K ﹤0.01% 519
2023
Q4 		$290K Sell
1,321
-16
-1% -$3.69K ﹤0.01% 502
2023
Q3 		$302K Buy
1,337
+41
+3% +$9.44K ﹤0.01% 483
2023
Q2 		$286K Hold
1,296
– – ﹤0.01% 504
2023
Q1 		$290K Hold
1,296
– – ﹤0.01% 496
2022
Q4 		$361K Hold
1,296
– – 0.01% 466
2022
Q3 		$271K Sell
1,296
-10
-0.8% -$2.24K ﹤0.01% 532
2022
Q2 		$308K Buy
1,306
+625
+92% +$127K ﹤0.01% 537
2022
Q1 		$122K Hold
681
– – ﹤0.01% 737
2021
Q4 		$147K Buy
+681
New +$134K ﹤0.01% 729

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

UMB Bank's UTHR Position: Q2 2026 in Review

UMB Bank reduced its United Therapeutics (UTHR) stake by 0.3% in Q2 2026, selling an estimated $2.25K and leaving 1,342 shares worth $727K. The position accounts for 0.01% of the portfolio, ranked #413.

UMB Bank first reported a position in UTHR in Q4 2021 and has held it in 19 quarters since. The position peaked at $798K in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • UMB Bank held 1,342 shares of United Therapeutics worth $727K as of Q2 2026.
  • UMB Bank sold 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
  • United Therapeutics made up 0.01% of UMB Bank's portfolio in Q2 2026, its #413 holding.
  • UMB Bank first reported a position in United Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's United Therapeutics position peaked at $798K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.